Montag & Caldwell, LLC Biogen Inc. Transaction History

Montag & Caldwell, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.21 Million - $1.56 Million	5,409 Added 10.26%	58,121 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $1.86 Million - $2.43 Million	6,576 Added 14.25%	52,712 $14.9 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $11.9 Million - $19.1 Million	46,136 New	46,136 $16 Million
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $197,361 - $217,548	-900 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $43,342 - $67,792	-200 Reduced 18.18%	900 $213,000
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $309,265 - $362,659	1,100	1,100 $344,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Montag & Caldwell, LLC, based on Form 13F filings with the SEC.

Stay updated on Montag & Caldwell, LLC with notifications on news.